Literature DB >> 10547123

Psychotropic drug utilization in long-term-care facilities for the elderly in Ontario, Canada.

D K Conn1, I Ferguson, K Mandelman, C Ward.   

Abstract

OBJECTIVE: Despite considerable data from a number of countries regarding psychotropic utilization in long-term-care facilities for the elderly, there has been a lack of similar data from Canada. The purpose of this study was to gather prescription data from a series of institutions in Ontario and to compare the results to those of other international studies.
METHOD: Single-day surveys were carried out in six homes for the aged, four nursing, homes, two retirement homes, and a veterans' center. The results were compared to those of recent studies from other countries.
RESULTS: The data revealed considerable differences in rates of prescription between different classes of institutions and between similarly classified institutions. The prescription rate of neuroleptics ranged from 11.8% (of patients) in retirement homes to 29.8% in nursing homes. Antidepressant use ranged from 12.2% in nursing homes to 24.6% in homes for the aged, and benzodiazepine use ranged from 22.5% in nursing homes to 36.4% in retirement homes.
CONCLUSIONS: The overall rate of prescription for psychotropic medications was somewhat lower than in most international studies. The rate of prescription of neuroleptics in nursing homes fell in the midrange of studies, somewhat higher than in recent studies from the United States and an earlier Italian study, but lower than in recent reports from Sweden, Austria, and Australia. The rate of neuroleptic use in homes for the aged was comparable to the rate in the U.S. studies. The overall rate of prescription of antidepressants and benzodiazepines appears to be comparable to that in recent studies from other countries.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10547123     DOI: 10.1017/s1041610299005797

Source DB:  PubMed          Journal:  Int Psychogeriatr        ISSN: 1041-6102            Impact factor:   3.878


  4 in total

Review 1.  Benzodiazepine Use, Misuse, and Harm at the Population Level in Canada: A Comprehensive Narrative Review of Data and Developments Since 1995.

Authors:  Yoko Murphy; Emily Wilson; Elliot M Goldner; Benedikt Fischer
Journal:  Clin Drug Investig       Date:  2016-07       Impact factor: 2.859

Review 2.  Use of sleep-promoting medications in nursing home residents : risks versus benefits.

Authors:  David K Conn; Robert Madan
Journal:  Drugs Aging       Date:  2006       Impact factor: 3.923

3.  Use of neuroleptics: study of institutionalized elderly people in Montreal, Que.

Authors:  Nathalie Champoux; Johanne Monette; Michèle Monette; Guillaume Galbaud du Fort; Christina Wolfson; Jean-Pierre Le Cruguel
Journal:  Can Fam Physician       Date:  2005-05       Impact factor: 3.275

4.  Psychotropic medication use in canadian long-term care patients referred for psychogeriatric consultation.

Authors:  Corinne E Fischer; Carole Cohen; Lauren Forrest; Tom A Schweizer; Donald Wasylenki
Journal:  Can Geriatr J       Date:  2011-11-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.